NYSEAMERICAN:EMAN - eMagin Stock Price, Price Target & More

eMagin trades on the New York Stock Exchange (NYSE)AMERICAN under the ticker symbol "EMAN."

eMagin (NYSEAMERICAN:EMAN) announced its quarterly earnings data on Thursday, May, 10th. The semiconductor company reported ($0.05) earnings per share for the quarter, missing analysts' consensus estimates of ($0.04) by $0.01. The semiconductor company earned $6.87 million during the quarter, compared to analyst estimates of $6.50 million. eMagin had a negative net margin of 69.91% and a negative return on equity of 57.13%. View eMagin's Earnings History.

eMagin is scheduled to release their next quarterly earnings announcement on Thursday, August, 9th 2018. View Earnings Estimates for eMagin.

3 equities research analysts have issued 12-month target prices for eMagin's stock. Their forecasts range from $4.00 to $4.00. On average, they expect eMagin's stock price to reach $4.00 in the next twelve months. View Analyst Ratings for eMagin.

eMagin saw a drop in short interest in May. As of May 15th, there was short interest totalling 1,283,783 shares, a drop of 1.5% from the April 30th total of 1,302,730 shares. Based on an average daily trading volume, of 55,739 shares, the days-to-cover ratio is presently 23.0 days. Approximately 3.6% of the shares of the company are short sold.

Some companies that are related to eMagin include Manz (M5Z), Nanoco (NANO), Cml Microsystems (CML), Trio-Tech International (TRT), Solitron Devices (SODI) and Terrascend (TER).

Media coverage about EMAN stock has trended positive this week, according to Accern. The research firm identifies negative and positive press coverage by analyzing more than twenty million blog and news sources in real-time. Accern ranks coverage of companies on a scale of -1 to 1, with scores nearest to one being the most favorable. eMagin earned a media sentiment score of 0.28 on Accern's scale. They also assigned press coverage about the semiconductor company an impact score of 45.24 out of 100, indicating that recent press coverage is somewhat unlikely to have an effect on the stock's share price in the next few days.

eMagin's stock is owned by a number of of institutional and retail investors. Top institutional investors include First Washington CORP (3.13%), Penn Capital Management Co. Inc. (1.61%) and Northern Trust Corp (0.20%). Company insiders that own eMagin stock include Awm Investment Company, Inc, Jill Wittels, Stephen Costello and Stillwater Holdings Llc. View Institutional Ownership Trends for eMagin.

EMAN stock was acquired by a variety of institutional investors in the last quarter, including Penn Capital Management Co. Inc., First Washington CORP and Northern Trust Corp. Company insiders that have bought eMagin stock in the last two years include Jill Wittels, Stephen Costello and Stillwater Holdings Llc. View Insider Buying and Selling for eMagin.

Shares of EMAN can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

One share of EMAN stock can currently be purchased for approximately $1.60.

eMagin has a market capitalization of $67.82 million.

eMagin's mailing address is 2070 Route 52 Building 334, HOPEWELL JUNCTION, NY 12533-3507, United States. The semiconductor company can be reached via phone at +1-845-8387900.